These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9822984)

  • 21. Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study.
    Hugues JN; Soussis J; Calderon I; Balasch J; Anderson RA; Romeu A;
    Hum Reprod; 2005 Mar; 20(3):629-35. PubMed ID: 15618252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study.
    Platteau P; Andersen AN; Balen A; Devroey P; Sørensen P; Helmgaard L; Arce JC;
    Hum Reprod; 2006 Jul; 21(7):1798-804. PubMed ID: 16571641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
    J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of recombinant equine follicle stimulating hormone (reFSH) to promote follicular growth in mares using a follicular suppression model.
    Jennings MW; Boime I; Daphna-Iken D; Jablonka-Shariff A; Conley AJ; Colgin M; Bidstrup LA; Meyers-Brown GA; Famula TR; Roser JF
    Anim Reprod Sci; 2009 Dec; 116(3-4):291-307. PubMed ID: 19237253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropin therapy for the treatment of anovulation and for ovarian hyperstimulation for IVF.
    Macklon NS; Fauser BC
    Mol Cell Endocrinol; 2002 Jan; 186(2):159-61. PubMed ID: 11900890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the efficacy of two doses of letrozole alone or with continuous recombinant follicle-stimulating hormone for ovulation induction in anovulatory women.
    Wang HY; Zheng PS
    Gynecol Obstet Invest; 2015; 79(4):250-5. PubMed ID: 25428607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian stimulation with human and recombinant gonadotropin - comparison of in vitro fertilization efficiency with use of time-lapse monitoring.
    Wdowiak A; Bojar I
    Reprod Health; 2015 Dec; 12():113. PubMed ID: 26667662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cycle and hormone changes during perimenopause: the key role of ovarian function.
    Burger HG; Hale GE; Dennerstein L; Robertson DM
    Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.
    Howles CM; Alam V; Tredway D; Homburg R; Warne DW
    Reprod Biomed Online; 2010 Feb; 20(2):182-90. PubMed ID: 20113956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A randomized, single-blind, parallel-controlled and multicentre study: compare the efficacy and safety of domestic and imported human recombinant FSH in WHO group Ⅱ anovulatory infertility].
    Zhou YZ; Shen H; Zuo WL; Xu YH; Deng XH; Chen YL; Gao Y; Wang XX; Xu W; Lai QH; Shi H; Liu W; He Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):258-63. PubMed ID: 27116983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular phase dynamics with combined aromatase inhibitor and follicle stimulating hormone treatment.
    Bedaiwy MA; Mousa NA; Esfandiari N; Forman R; Casper RF
    J Clin Endocrinol Metab; 2007 Mar; 92(3):825-33. PubMed ID: 17192292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
    Messinis IE; Milingos S; Zikopoulos K; Hasiotis G; Seferiadis K; Lolis D
    Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
    Buckler HM; Evans CA; Mamtora H; Burger HG; Anderson DC
    J Clin Endocrinol Metab; 1991 Jan; 72(1):116-24. PubMed ID: 1824706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J; Fábregues F; Creus M; Puerto B; Peñarrubia J; Vanrell JA
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).
    Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E
    Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure.
    Welt CK; Hall JE; Adams JM; Taylor AE
    J Clin Endocrinol Metab; 2005 Feb; 90(2):826-30. PubMed ID: 15562017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
    Lledó B; Dapena P; Ortiz JA; Morales R; Llacer J; Bernabeu R
    Pharmacogenet Genomics; 2016 Jun; 26(6):288-93. PubMed ID: 26959715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.